化合物NVP-BEP800 T2114
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 847559-80-2 | ¥2,780.00 | 询底价 |
1 mg | 847559-80-2 | ¥311.00 | 询底价 |
10 mg | 847559-80-2 | ¥1,490.00 | 询底价 |
5 mg | 847559-80-2 | ¥828.00 | 询底价 |
1 mL | 847559-80-2 | ¥913.00 | 询底价 |
100 mg | 847559-80-2 | ¥5,890.00 | 询底价 |
2 mg | 847559-80-2 | ¥459.00 | 询底价 |
50 mg | 847559-80-2 | ¥4,130.00 | 询底价 |
500 mg | 847559-80-2 | ¥11,900.00 | 询底价 |
Product Introduction
Bioactivity
英文名: VER-82576
描述: VER-82576 (NVP-BEP800) 是一种可口服的,选择性的 Hsp90抑制剂,对 Hsp90β 的 IC50值为 58 nM,对 Hsp90 家族成员 Trap-1 和 Grp94 的选择性超过 70 倍。
细胞实验: Cells are exposed to NVP-BEP800 for 24 hours. Cell proliferation is determined using either sulforhodamine B for adherent cells or MTS assay for suspension cells or those showing low adherence. Cell death is determined using a ToxiLight nondestructive cytotoxicity bioassay kit. Cell cycle progression is determined by RNase A/propidium iodide staining following fixation in 70% ethanol. Caspase-3/7 activity is determined using a homogeneous caspase activity kit.(Only for Reference)
激酶实验: Competitive binding fluorescent polarization assay: Recombinant Hsp90β, TAMRA-radicicol, or various concentrations of NVP-BEP800 is added in assay buffer (50 mM TRIS pH 7.4, 5 mM MgCl2, 150 mM KCl, and 0.1% CHAPS), mixed, and incubated at room temperature for 30 to 45 minutes prior to reading. The 2D-FIDA-based HTS assay based on confocal technologies monitors the decreased fluorescence polarization on displacement of the high affinity ligand TAMRA-radicicol from Hsp90β by NVP-BEP800. The concentration of NVP-BEP800 which inhibits Hsp90β by 50% is determined from the competition curve.
体外活性: 在A375恶性黑色素移植瘤模型中,NVP-BEP800(15或 30 mg/kg/day,p.o.)处理15天,可剂量依赖性降低B-Raf和Akt磷酸化水平,且有抗癌活性,NVP-BEP800(15和30 mg/kg/day)处理,T/C值分别为53%和6%,每天30 mg/kg则几乎抑制全部肿瘤.在BT-474乳腺癌移植瘤中,NVP-BEP800处理可提高Hsp90-p23复合体解离,并降低稳定态ErbB2,p-Akt和p-S6水平,,该作用呈剂量依赖性,NVP-BEP800(30 mg/kg/day)处理可使肿瘤衰退38%.每天15 mg/kg处理则T/C为36%.
体内活性: NVP-BEP800有效抑制包括A375细胞(GI50:38 nM)和PC3细胞(GI50:1.05 μM)在内的多种肿瘤细胞系增殖。在A2058和A549细胞中,NVP-BEP800(GI50的5倍)可提高G2-M期百分数。在BT-474细胞中,NVP-BEP800可浓度依赖性地引起Akt和ErbB2去磷酸化、ErbB2降解和Hsp70诱发(IC50:218/39.5/137/207 nM)。Hsp70浓度为10 μM时, NVP-BEP800对密切相关的GHKL ATP酶、拓扑异构酶 II和结构不相关的ATP酶均无明显抑制效果。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 1mg/ml
关键字: HSP | NVP-BEP 800 | Heat shock proteins | VER 82576 | NVP-BEP-800 | VER82576 | VER-82576 | Inhibitor | inhibit
相关产品: Elesclomol | Radicicol | HSF1A | Pimitespib | BIIB021 | Gamitrinib TPP | AMP-PCP | Chetomin | TRAP1-IN-1 | Pifithrin-μ
相关库: HIF-1 Signaling Pathway Compound Library | Anti-Breast Cancer Compound Library | Bioactive Compounds Library Max | Endoplasmic Reticulum Stress Compound Library | Inhibitor Library | Anti-Cancer Active Compound Library | Hematonosis Compound Library | Metabolism Compound Library | Orally Active Compound Library | NO PAINS Compound Library
化合物NVP-BEP800 T2114信息由TargetMol中国为您提供,如您想了解更多关于化合物NVP-BEP800 T2114报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途